TERN Terns Pharma Total Asset Value of Company

This chart of Terns Pharmaceuticals (TERN) share prices illustrates asset dynamics that currently stand at 694.66. Terns Pharmaceuticals (TERN) minimizes risks by developing a broad portfolio of small molecules for the therapy of metabolic disorders and gastrointestinal issues. The business focuses on replacing injections with convenient tablets for weight loss treatment. The company may transfer drug rights to major partners in the future.

TERN (Terns Pharmaceuticals) Company Total Assets history from 07/04/2022 to 05/16/2026

Analytical breakdowns and data insights for company Terns Pharmaceuticals Inc (TERN)

- stock quotes and analyst forecast:

Share Price ternspharma.com|TERN - Price Target Chart

- market capitalization data:

Market Valuation Terns Corp|TERN - Enterprise Value

- issuer book value statistics:

Accounting Value of a Share Terns Pharmaceuticals|TERN - Book Capitalization|Market Capitalization to Book Value Ratio ternspharma.com|TERN - Aggregate Company Assets

- debt burden and liquidity indicators:

All Debt to Shareholders' Equity Ratio Terns Pharmaceuticals|TERN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Terns Corp|TERN - Company Aggregate Debts|Debts to Book Capitalization Terns Corp|TERN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Terns Pharmaceuticals|Critical Liquidity ternspharma.com

- net income and valuation multiples indicators:

TERN - Net Profit

Fundamental valuation:Terns Pharmaceuticals

Manufactured products of Terns Pharmaceuticals

Total assets determine the aggregate value of the company's resources, expressing the fundamental base through a reverse calculation from the return on assets (ROA). The dynamics of total assets reflect Terns Pharmaceuticals' dependence on external financing, as the absence of commercial products makes the asset value critically sensitive to capital inflows required to conduct clinical trials for gastrointestinal disease therapies.

Key competitors